Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papilledema | 4 | 2016 | 87 | 0.640 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2018 | 8 | 0.610 |
Why?
|
| Cellulitis | 1 | 2018 | 62 | 0.590 |
Why?
|
| Scalp | 1 | 2018 | 59 | 0.580 |
Why?
|
| Pseudotumor Cerebri | 3 | 2016 | 67 | 0.560 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 92 | 0.550 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2011 | 51 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2018 | 3843 | 0.270 |
Why?
|
| Optic Nerve | 2 | 2016 | 119 | 0.220 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1970 | 0.210 |
Why?
|
| Vision Disorders | 2 | 2017 | 221 | 0.200 |
Why?
|
| Giant Cell Arteritis | 2 | 2019 | 59 | 0.170 |
Why?
|
| Vision, Binocular | 1 | 2019 | 29 | 0.150 |
Why?
|
| Diplopia | 1 | 2019 | 38 | 0.150 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 50 | 0.150 |
Why?
|
| Visual Acuity | 3 | 2019 | 707 | 0.150 |
Why?
|
| Optic Chiasm | 1 | 2018 | 15 | 0.150 |
Why?
|
| Temporal Arteries | 1 | 2019 | 40 | 0.150 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2018 | 19 | 0.150 |
Why?
|
| Retinal Artery | 1 | 2017 | 17 | 0.140 |
Why?
|
| Eye Foreign Bodies | 1 | 2017 | 13 | 0.140 |
Why?
|
| Metals | 1 | 2017 | 64 | 0.140 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 71 | 0.140 |
Why?
|
| Acetazolamide | 1 | 2016 | 31 | 0.130 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2016 | 28 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2018 | 217 | 0.120 |
Why?
|
| Lymphoma | 1 | 2018 | 335 | 0.120 |
Why?
|
| Embolization, Therapeutic | 1 | 2017 | 225 | 0.120 |
Why?
|
| Horner Syndrome | 1 | 2015 | 16 | 0.120 |
Why?
|
| Neuromyelitis Optica | 2 | 2012 | 34 | 0.110 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 177 | 0.110 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2014 | 16 | 0.110 |
Why?
|
| Third Ventricle | 1 | 2014 | 33 | 0.110 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2014 | 95 | 0.110 |
Why?
|
| Pelvic Floor | 1 | 2013 | 37 | 0.110 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2013 | 29 | 0.100 |
Why?
|
| Choroid | 1 | 2013 | 41 | 0.100 |
Why?
|
| Career Choice | 1 | 2014 | 161 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2173 | 0.100 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 88 | 0.100 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2013 | 48 | 0.100 |
Why?
|
| Retinitis | 1 | 2012 | 18 | 0.100 |
Why?
|
| Neurology | 1 | 2014 | 120 | 0.100 |
Why?
|
| Cat-Scratch Disease | 1 | 2012 | 32 | 0.100 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2012 | 15 | 0.090 |
Why?
|
| Behavioral Symptoms | 1 | 2012 | 25 | 0.090 |
Why?
|
| Ophthalmology | 1 | 2014 | 198 | 0.090 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2010 | 19 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 615 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 50 | 0.090 |
Why?
|
| Optic Neuritis | 1 | 2011 | 35 | 0.090 |
Why?
|
| Education, Medical | 1 | 2014 | 303 | 0.090 |
Why?
|
| Adult | 8 | 2018 | 31830 | 0.080 |
Why?
|
| Biopsy | 3 | 2019 | 1300 | 0.080 |
Why?
|
| Optic Nerve Diseases | 1 | 2010 | 89 | 0.080 |
Why?
|
| Glioma | 1 | 2014 | 538 | 0.080 |
Why?
|
| Humans | 18 | 2019 | 133547 | 0.070 |
Why?
|
| Autoantibodies | 1 | 2010 | 467 | 0.070 |
Why?
|
| Tomography, Optical Coherence | 3 | 2017 | 567 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2013 | 881 | 0.060 |
Why?
|
| Male | 9 | 2019 | 65791 | 0.060 |
Why?
|
| Female | 11 | 2019 | 71537 | 0.060 |
Why?
|
| Middle Aged | 6 | 2018 | 29254 | 0.060 |
Why?
|
| Fluorescein Angiography | 2 | 2017 | 154 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 1782 | 0.040 |
Why?
|
| Blood Sedimentation | 1 | 2019 | 30 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5466 | 0.030 |
Why?
|
| Aged | 4 | 2019 | 21637 | 0.030 |
Why?
|
| Visual Field Tests | 1 | 2016 | 53 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 471 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2016 | 53 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 122 | 0.030 |
Why?
|
| Clonidine | 1 | 2015 | 37 | 0.030 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2015 | 37 | 0.030 |
Why?
|
| Visual Fields | 1 | 2016 | 147 | 0.030 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 27 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2016 | 197 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 238 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 727 | 0.030 |
Why?
|
| New York | 1 | 2013 | 73 | 0.030 |
Why?
|
| Methotrexate | 1 | 2016 | 354 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2019 | 17401 | 0.030 |
Why?
|
| Cocaine | 1 | 2015 | 208 | 0.030 |
Why?
|
| Craniotomy | 1 | 2014 | 106 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2016 | 329 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 312 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 7181 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2016 | 416 | 0.020 |
Why?
|
| Bartonella henselae | 1 | 2012 | 19 | 0.020 |
Why?
|
| Prednisone | 1 | 2013 | 288 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1198 | 0.020 |
Why?
|
| Azithromycin | 1 | 2012 | 47 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 562 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2015 | 374 | 0.020 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2012 | 86 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2013 | 401 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 824 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 5073 | 0.020 |
Why?
|
| Child | 3 | 2015 | 25761 | 0.020 |
Why?
|
| Infant | 2 | 2015 | 13172 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2015 | 14804 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 392 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 2657 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 914 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 3088 | 0.010 |
Why?
|
| Adolescent | 2 | 2015 | 20516 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2511 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9869 | 0.010 |
Why?
|